Abstract
Recently, we identified the homeodomain transcription factor CUTL1 as important mediator of cell migration and tumor invasion downstream of transforming growth factor β (TGFβ). The molecular mechanisms and effectors mediating the pro-migratory and pro-invasive phenotype induced by CUTL1 have not been elucidated so far. Therefore, the aim of this study was to identify signaling pathways downstream of CUTL1 which are responsible for its effects on tumor cell migration. We found that the reduced motility seen after knock down of CUTL1 by RNA interference is accompanied by a delay in tumor cell spreading. This spreading defect is paralleled by a marked reduction of Src protein levels. We show that CUTL1 leads to Src protein stabilization and activation of Src-regulated downstream signaling molecules such as RhoA, Rac1, Cdc42 and ROCK. In addition, we demonstrate that CUTL1 decreases proteasome-mediated Src protein degradation, possibly via transcriptionally upregulating C-terminal Src kinase (Csk). Based on experiments using Src knockout cells (SYF), we present evidence that Src plays a crucial role in CUTL1-induced tumor cell migration. In conclusion, our findings linking the pro-invasive transcription factor CUTL1 and the Src pathway provide important new insights in the molecular effector pathways mediating CUTL-induced migration and invasion.
Similar content being viewed by others
References
Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T et al. (1996). Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246–20249.
Burridge K, Chrzanowska-Wodnicka M . (1996). Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463–518.
Hakak Y, Martin GS . (1999). Ubiquitin-dependent degradation of active Src. Curr Biol 9: 1039–1042.
Hynes RO . (1992). Integrins: versatility and signaling in cell adhesion. Cell 69: 11–25.
Hynes RO, Lander AD . (1992). Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 68: 303–322.
Johnson FM, Saigal B, Talpaz M, Donato NJ . (2005). Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 11: 6924–6932.
Kaido T, Yebra M, Cirulli V, Montgomery AM . (2004). Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J Biol Chem 279: 53762–53769.
Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P . (1999). Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J 18: 2459–2471.
Lowell CA, Soriano P . (1996). Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories. Genes Dev 10: 1845–1857.
Lowry WE, Huang J, Ma YC, Ali S, Wang D, Williams DM et al. (2002). Csk, a critical link of g protein signals to actin cytoskeletal reorganization. Dev Cell 2: 733–744.
Ma YC, Huang J, Ali S, Lowry W, Huang XY . (2000). Src tyrosine kinase is a novel direct effector of G proteins. Cell 102: 635–646.
Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, Poulsom R et al. (2005). CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7: 521–532.
Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J et al. (1997). Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650–653.
Nepveu A . (2001). Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270: 1–15.
Parsons JT . (1996). Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 8: 146–152.
Parsons JT, Parsons SJ . (1997). Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 9: 187–192.
Price JT, Bonovich MT, Kohn EC . (1997). The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 32: 175–253.
Riento K, Ridley AJ . (2003). Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4: 446–456.
Roskoski Jr R . (2004). Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324: 1155–1164.
Stahle M, Veit C, Bachfischer U, Schierling K, Skripczynski B, Hall A et al. (2003). Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci 116: 3835–3846.
Stover DR, Liebetanz J, Lydon NB . (1994). Cdc2-mediated modulation of pp60c-src activity. J Biol Chem 269: 26885–26889.
Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y et al. (2005). ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Res 65: 1858–1867.
Thomas SM, Brugge JS . (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513–609.
Weber CK, Liptay S, Wirth T, Adler G, Schmid RM . (2000). Suppression of NF-kB activity by sulfasalazine is mediated by direct inhibition of IkB kinases alpha and beta. Gastroenterology 119: 1209–1218.
Zheng XM, Resnick RJ, Shalloway D . (2000). A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 19: 964–978.
Acknowledgements
This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) to PM. We thank Susanne Braun for expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aleksic, T., Bechtel, M., Krndija, D. et al. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation. Oncogene 26, 5939–5949 (2007). https://doi.org/10.1038/sj.onc.1210398
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210398
- Springer Nature Limited
Keywords
This article is cited by
-
Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma
Cell Death Discovery (2023)
-
CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers
Nature Reviews Cancer (2014)
-
Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on theENCODE array
BMC Genomics (2013)
-
MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
Nature Communications (2011)